BPCE
RGEN icon

Bank Pictet & Cie (Europe)’s Repligen RGEN Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,451
Closed -$216K – 170
2024
Q3 		$216K Sell
1,451
-693
-32% -$99.4K 0.01% 148
2024
Q2 		$270K Buy
2,144
+664
+45% +$104K 0.01% 142
2024
Q1 		$272K Sell
1,480
-1,674
-53% -$319K 0.01% 156
2023
Q4 		$567K Buy
3,154
+1,001
+46% +$156K 0.02% 173
2023
Q3 		$342K Buy
+2,153
New +$352K 0.01% 206
2023
Q2 		– Sell
-2,210
Closed -$372K – 280
2023
Q1 		$372K Buy
2,210
+21
+1% +$3.75K 0.02% 143
2022
Q4 		$371K Buy
2,189
+345
+19% +$62.6K 0.02% 135
2022
Q3 		$345K Buy
1,844
+300
+19% +$63.3K 0.02% 134
2022
Q2 		$251K Buy
+1,544
New +$244K 0.01% 143

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s RGEN Position: Q4 2024 in Review

Bank Pictet & Cie (Europe) sold out of Repligen (RGEN) in Q4 2024, closing a stake of 1,451 shares — an estimated $216K sold.

Bank Pictet & Cie (Europe) first reported a position in RGEN in Q2 2022 and held it in 9 quarters. The position peaked at $567K in Q4 2023. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • Bank Pictet & Cie (Europe) reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 1,451 Repligen shares in Q4 2024, an estimated $216K.
  • Bank Pictet & Cie (Europe) first reported a position in Repligen in Q2 2022 and held it in 9 quarters.
  • Bank Pictet & Cie (Europe)'s Repligen position peaked at $567K in Q4 2023.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2024, filed 30 Jan 2025.